1066vip威尼斯 - Apple App Store

    The 2018 seminar on the new progress of laboratory diagnosis of rheumatoid arthritis was successfully held on December 7th at Shanghai Xinghui Center. 22 experts from Jiangsu, Zhejiang, Hunan, Hubei and Heilongjiang provinces and rheumatoid clinical experts attended the seminar. This meeting. The conference focused on the current state of rheumatoid arthritis (RA) detection technology, new research on matrix metalloproteinase 3 (hereinafter referred to as MMP-3), Japanese rheumatoid arthritis treatment guidelines and clinical application of MMP-3 project. Warm academic exchanges. The meeting was hosted by Professor Han Wei, Director of the Chinese Journal of Laboratory Medicine. Professor Han Wei introduced the promotion of the topic of autoimmune disease testing in China, saying that “I hope that through the exchange of clinical and testing, we can see more directions and choices in the field of rheumatoid arthritis testing, and then conduct further research. To provide better RA diagnosis and treatment for the clinic, and to provide a better experience for patients."
Successful replay of the seminar
Opening speech at the beginning of the meeting, Mr. Tong Wenbin, executive vice president of Runda Medical He delivered a speech at the opening ceremony and said that since its establishment in 1999, Runda Group has not only developed product supply, intensive services, third-party laboratories, medical associations, regional inspection centers, etc. downstream of the industrial chain, but also continuously enhanced core technologies. Develop self-produced business upstream of the industrial chain. MMP-3 is a very good project, and it is very effective in developed countries. I hope that through this combination of clinical and testing, we can make effective recommendations for the diagnosis and treatment of RA diseases and make a real contribution to patients. .

     Wonderful Questions 1: Research progress of MMP-3 in RA diagnosis and treatment. This link was presided over by Professor Wang Wei, the director of the Department of Clinical Laboratory of Tongde Hospital of Zhejiang Province, the director of the Genetic Testing Center, and the Standing Committee of the Laboratory of Traditional Chinese Medicine and Western Medicine. Professor Han Zhenge, Director of the Laboratory of Guanghua Hospital affiliated to Shanghai University of Traditional Chinese Medicine, conducted a comprehensive review of the value of rheumatoid arthritis disease surveillance, MMP-3 and RA activity, and MMP-3 as an early diagnostic indicator of RA. explain. Professor Han said, "Experimental studies have shown that MMP-3 detection can be used for early diagnosis. MMP-3 levels are associated with RA activity and bone destruction, and can be used for monitoring therapeutic effects." Wonderful topic 2: Matrix metalloproteinases -3 and evaluation of ultrasound US7 score in rheumatoid arthritis. This session was presided over by Professor Yang Chen, director of the Medical Laboratory of Suzhou Hospital of Nanjing Medical University and Suzhou Medical College. Professor Zhou Ling from the Department of Rheumatology and Immunology, Shanghai Changzheng Hospital introduced the related research on the evaluation of matrix metalloproteinase-3 and ultrasound US7 score in rheumatoid arthritis from a clinical perspective. Professor Zhou mentioned that "MMP-3 combined with US7 scores jointly evaluated RA activity, which is superior to US7 score alone, and no difference with MMP-3." "Baseline MMP-3 can be used to evaluate the prognosis of RA, which is very good. Predictor of imaging (ultrasound)." Wonderful topic 3: Autoimmune antibody laboratory test. This link was presided over by Professor Wang Xianjun, director of the Department of Clinical Laboratory of Hangzhou First Hospital affiliated to Zhejiang University School of Medicine. Department of Rheumatology and Immunology, First Affiliated Hospital of Jiangsu Medical University (Jiangsu Provincial People's Hospital), Deputy Director of the Department of Rheumatology and Immunology of the Chinese Academy of Integrated Traditional and Western Medicine, Zhang Xiaojun, Member of the Standing Committee of the Committee on Immunological Diseases, has been engaged in the treatment of rheumatoid diseases for many years. Various indicators for laboratory testing of autoimmune antibodies were introduced, including MMP-3. Director Zhang explained the clinical situation of different types of non-organ-specific autoantibodies in different cases of RA. At the same time, it also provided suggestions for the clinical use of MMP-3, a new diagnostic tool for rheumatoid arthritis. Tr